Infections Following Facial Composite Tissue Allotransplantation—Single Center Experience and Review of the Literature
Bettina M. Knoll(Brigham and Women's Hospital), Francisco M. Marty(Brigham and Women's Hospital), Sarah P. Hammond(Dana-Farber Cancer Institute), Sophia Koo(Dana-Farber Brigham Cancer Center), Stefan G. Tullius(Brigham and Women's Hospital), Nicolas C. Issa(Dana-Farber Cancer Institute), Lindsey R. Baden(Brigham and Women's Hospital), Bohdan Pomahač(Yale University)
Cited by 49
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981